I hold these stock.

DYOH (do your own homework.)

To-day there was a slight drop in price, but number of analysts are giving favourable reports.

What triggered my interest was better than expected results and if I am right looking at charts it shows an inverted head and shoulders. Hopefully a good sign. Also the current rate of Share price growth is about 90% pa over the last 5weeks. This is unlikely to continue indefinitely but SP could hit 850p over next few weeks.

To-day at close, there were some large buys of about 5million shares. 40million approx.

Another trigger for me was the following which should increase earnings.

Aviva to form JV in Taiwan with First FinancialAFX
LONDON (Thomson Financial) - Aviva PLC, the UK's largest insurer, said it has entered into a joint venture with First Financial Holding Co Ltd to sell insurance and pension products in Taiwan. The joint venture company, First-Aviva, will distribute long-term savings and pension products in Taiwan through an exclusive agreement with First Financial's flagship unit, First Commercial Bank. Aviva, which will have a 49 pct stake in the joint venture, added that the initial paid up capital of the new company will be 34 mln stg.First Commercial Bank is Taiwan's second largest bank network, with five mln retail customers, it added.TFN.newsdesk@thomson.comkkb/faj/slm




Date: Wednesday 25 Apr 2007
LONDON (ShareCast) - If the message gets home that Aviva will not bid for Prudential, the stock should rebound strongly, especially if Aviva can sustain its current impressive performance. There is still work to be done but, at 794.5p, the shares are a strong buy says the Independent.
Date: Tuesday 24 Apr 2007
LONDON (ShareCast) - Aviva stood out among the risers on a tough day for blue chip stocks. The life insurer posted an upbeat first quarter statement with brokers pleased with the numbers.



DYOH

arguably too late now, but well spotted if you jumped in short when it broke 200 dma at 380

Personally, I do not think it's too late at all, but for a meaningful return, entry is going to be crucial.

From Merrill Lynch today:
"Aviva has reported FY results. These were very mixed indeed. On the one hand
operating profits on both bases were ahead, but the net profit numbers and
consequently the NAVs were well short.
The IFRS NAV was 374p per share (2008 421p) well short our 447p forecast.
Even after adding back the pensions deficit the NAV of 436p per share was still
light. The headline EV came in at 471p per share (2008 495p) was well short of our
578p forecast and 486p last year. This includes goodwill; stripping this out the
net figure is around 351p, unchanged from last year and well short of our 455p
forecast.
We have a neutral recommendation on Aviva and as such it is our least preferred
UK life name. That said, the shares are inexpensively rated after a protracted
period of underperformance. At 8x 2011E EPS, around 20% below EV and a
dividend yield of more than 6%, the shares are well supported. However, these
are disappointing figures with significant shortfalls in both the EV and IFRS book
values. We need to investigate further why this is."

18 March 2010
"AVIVA ANNOUNCES ENTRY INTO INDONESIAN MARKET

Aviva acquires a 60% stake in PT Asuransi Winterthur Life Indonesia

Indonesia is one of the fastest growing life insurance markets in Asia

Combines Aviva's strong product expertise and brand with PT Asuransi Winterthur Life Indonesia's existing distribution

Consistent with Aviva's long term strategy to build a presence in key markets in South East Asia as part of the group's diversified footprint"

Aviva Signs 5-Year Life Protection Deal With Santander UK

Today : Tuesday 3 August 2010
U.K. life insurer Aviva PLC (AV.LN) said Tuesday its U.K. business has signed an exclusive five year agreement with Santander for the distribution of Aviva's life protection insurance products in the U.K. from June 2011.

MAIN FACTS:

-Agreement covers the sale of Aviva's core protection products, including life insurance, critical illness and income protection, which will be sold by Santander through its 1,300 U.K. branches, online and over the telephone.

-Santander will sell the products under dual Aviva/Santander brands.

-No financial terms disclosed.

anyone else hear a rumour about a takeover bid?

"Aviva headed the blue chip leaderboard, on news it had rejected an approach from RSA for its general insurance business, investors hoping a higher bid will be forthcoming."

Personally I would be very surprised if this actually came to anything. AV. has fingers in many pies in the insurance sector & I think that this is totally intentional in order to be spread the risk.

thanks harry.

"Standard & Poor's maintained its "buy" recommendation and 505p target price for Aviva following the insurance group's approach from RSA to buy its general insurance operation in the UK, Ireland and Canada for 5 billion pounds, which was subsequently rejected. The broker finds it hard to envisage RSA, which has a market capitalisation of 4.3 billion pounds, being both willing and able to make a sufficiently attractive cash offer. Furthermore, the proposed transaction looks to be economically irrational from shareholders' point of view. A better way to do it, in S&P's opinion, would be to pool the target businesses of both Aviva and RSA in a 'newco', which it believes offers at least the same synergy benefits as an acquisition."

23rd Nov:
StockMarketWire.com
Aviva initiated with buy rating at Jefferies, target price 452p.

24th Nov:
StockMarketWire.com
Aviva downgraded to equal-weight from overweight at Morgan Stanley.

Anyone for 5 quid.

Interim Management Statement.

Part of the broker note from UBS:
"On track for full year
Q1 reported EV of 576p looks in line with the expected level for this time of year (FY10 542p) and on track for our full year forecast. The outlook comments are positive, particularly for general insurance, and the financial targets are reiterated. IGD surplus fell from 3.8bn to 3.5bn.
Valuation 470p PT based on Price/EV
The stock offers value on earnings (IFRS PER 9x, sector 12x, EEV PER 6x, sector 7x), but EPS dilution remains a risk until the group completes its disposals.
Price/EV 80% (sector 86%) and a yield of 6.2% (sector 4.8%) also suggest value.
We remain Neutral, however, as the next expected newsflow is further dilutive disposals."

Harry - I've had my current tranch from 383 - + 16p dividend paid today. I'm looking to sell - maybe even today - with a view to pick them up again. I hold them in a SIPP and over the last year, they have been fantastic (for me).

RNS Number : 9668I

Aviva PLC

23 June 2011

23 June 2011

AVIVA TO SELL RAC FOR GBP1 BILLION

-- Aviva to sell RAC to The Carlyle Group for GBP1.0 billion -- Price represents 17 times 2010 net earnings -- The sale is consistent with Aviva's strategic focus on insurance and savings businesses in its priority markets

Aviva plc ("Aviva") announces that it has agreed to sell RAC Limited ("RAC"), the second largest UK roadside assistance provider, to The Carlyle Group ("Carlyle") for GBP1.0 billion*. The transaction values RAC at 17 times 2010 net earnings**. Completion, which is subject to regulatory and competition approvals, is expected at the end of the third quarter of 2011.

Carlyle, a global alternative asset manager, with significant experience of investing in UK companies, is fully supportive of the RAC management team, led by RAC's Managing Director Angela Seymour-Jackson, and its strategy to profitably grow the business.

Andrew Moss, Group Chief Executive of Aviva, said:

"The sale of RAC is another important step for Aviva and realises significant value for our shareholders. Together with the recent partial disposal of Delta Lloyd, it demonstrates clear delivery of our strategy and provides the flexibility to deepen our presence in the priority markets where we have strength and scale."

Strategic rationale for the sale

The sale supports Aviva's strategy to focus on insurance and savings businesses in its priority markets and represents further significant progress in the transformation of Aviva's portfolio. The proceeds, which will be held as cash on the balance sheet, will enhance liquidity and further strengthen Aviva's balance sheet, enabling Aviva to continue to invest in its priority markets. In addition to the strategic benefits, Aviva remains confident in meeting the group's near-term financial targets.

Financial impact of the sale on Aviva

Based on 31 December 2010 results, this transaction will increase net assets by GBP0.6 billion and tangible net assets by GBP1.0 billion, or approximately 37p per share. Aviva's IGD surplus will improve by GBP0.2 billion. The accounting profit on disposal is expected to be GBP0.6 billion.

Aviva will retain the RAC (2003) pension scheme which at 31 December 2010 had an IAS19 deficit of approximately GBP160 million. On completion Aviva will make a one off contribution of GBP67 million into the scheme.

Future commercial relationship between Aviva and RAC

The sale of RAC is consistent with Aviva UK's strategy of maximising the benefits of operating life and general insurance together under one strong brand. Aviva will continue its commercial relationship with RAC both as a key underwriter of motor insurance on RAC's panel and as a partner, selling RAC breakdown cover to Aviva's customers. As RAC develops its business and extends its product offering both parties will seek to find new areas where they can work closely together.

J.P. Morgan Cazenove acted as sole financial adviser to Aviva.

Limited out of these @439 so flat for now.

Back in @424.46p

Back in the money here.

rumours of a 6 a share take over doing the rounds.... fingers crossed

Yes the rumours started yesterday in the Guardian - hence the spike this morning. It would be nice but........